England v Italy: Six Nations 2025 – live
Arsenal v Liverpool: Women’s FA Cup quarter-final – live
Labor was warned its perceived ‘one-sided’ Israel support over Gaza raised social cohesion concerns
Internet shutdowns at record high in Africa as access ‘weaponised’
EU ambassador to China urges Beijing to stop building coal-fired power plants
Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business
AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid pandemic.
Britain’s biggest drugmaker has agreed to take over the Seattle-based company Icosavax, which is developing a potential vaccine for two common respiratory diseases.
More Stories
I keep fantasising about living in total solitude in a forest
Microsoft unveils chip it says could bring quantum computing within years
Five years on from the pandemic, the right’s fake Covid narrative has been turbo-charged into the mainstream | Laura Spinney